Companies formed
Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.
Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
1928 Foundation
Platform to promote critical thought on India and British Indians.
Incorporated in March 2022
Origin: Oxford University, Department of Physiology, Anatomy and Genetics
OxProx
To improve the ESG outcomes of publicly traded corporations by enhancing the efficacy of shareholder ownership rights.
Incorporated in February 2022
Origin: Oxford University, Kellogg College
OxONN
Optical neural networks.
Incorporated in January 2022
Origin: Oxford University, Department of Physics
2021
Alethiomics
To develop new methodologies for single cell genomics.
Incorporated in December 2021
Origin: Oxford University, Weatherall Institute for Molecular Medicine
OxDx
To develop and commercialise a rapid non-lab based diagnostic test for viral infections, with the first focus on Covid19.
Incorporated in December 2021
Origin: Oxford University, Department of Physics
Human Centric DD
To discover significantly de-risked novel drug targets for licensing and in-house development.
Incorporated in December 2021
Origin: Oxford University, Nuffield Department of Clinical Medicine
Reg Metrics
Oxford Global Guidance (OGG) is an online tool for providing guidance on medical device classification.
Incorporated in November 2021
Origin: Oxford University, Department of Engineering Science
Nature-based Insetting
Social enterprise focusing on assessment of the ecological impact of industry supply chain and manufacturing and associated remedations.
Incorporated in November 2021
Origin: Oxford University, Department of Zoology
OxCarbon
To provide data curation and maintenance services to commercial entities involved in carbon offset markets.
Incorporated in October 2021
Origin: Oxford University, Geography
RQ Biotechnology
To develop therapeutic antibodies.
Incorporated in October 2021
Origin: Oxford University, Medical Sciences
RAIQC
Software to train radiologists.
Incorporated in October 2021
Origin: Oxford University, Oncology
QuantrolOx
Machine learning algorithm and codes for quantum computers.
Incorporated in October 2021
Origin: Oxford University, Department of Materials
OxCCU
To optimise the catalyst performance and highlight the advantages of a catalyst to create green fuel for the aviation sector through carbon capture.
Incorporated in August 2021
Origin: Oxford University, Department of Chemistry
Sandymount
Development and characterisation of novel, first-in-class, selective and potential small molecule inhibitors targeting the YEATS Domain (YD) of MLLT1 and MLLT3.
Incorporated in August 2021
Origin: Oxford University, NDM, RDM, NDORMS
EndLyz Therapeutics Inc
The company has been created by the Dementia Discovery Fund. The Company’s mission is to develop disease-modifying therapeutics that restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease and other dementias.
Incorporated in July 2021
Origin: Oxford University, Department of Physiology, Anatomy and Genetics
Amber Therapeutics
To develop a bioelectronic platform with an initial focus on treating urinary incontinence.
Incorporated in June 2021
Origin: Oxford University, Department of Engineering Science
LiliumX
LiliumX uses a unique protein technology platform to facilitate scalable discovery of first-in-class bispecific biologics
Incorporated in May 2021
Origin: Oxford University, Department of Biochemistry
Oxford Green Innotech
Carbon-free transformation of ammonia waste.
Incorporated in March 2021
Origin: Oxford University, Department of Chemistry
OxVax
The technology consists of two patent families which collectively enable the development of cost effective, off-the-shelf vaccines based on a proprietary dendritic cell subset for the treatment of solid tumour cancers. The technology overcomes certain key roadblocks previously associated with dendritic cell vaccine technology.
Incorporated in March 2021
Origin: Oxford University, Sir William Dunn School of Pathology
Curacode
Cutting edge laser technology company.
Incorporated in February 2021
Origin: Oxford University, Department of Engineering Science
© Oxford University Innovation